Showing results (471-480 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|August 2, 2012
A pilot, prospective, open-label simplification study to evaluate the safety, efficacy, and pharmacokinetics of once-daily lopinavir-ritonavir monotherapy in HIV-HCV coinfected patients: the MONOCO studyCurtis Cooper, Charles la Porte, Harout Tossonian, et al.
HIV Clinical Trials|August 2, 2012
Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopyJaime H Vera, Lucy J Garvey, Joanna M Allsop, et al.
HIV Clinical Trials|January 10, 2017
Efficacy and safety of "unboosting" atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DFMarianne Harris, Bruce Ganase, Birgit Watson, et al.
HIV Clinical Trials|October 27, 2010
Simplification from protease inhibitors to once- or twice-daily raltegravir: the ODIS trialEugenia Vispo, Pablo Barreiro, Ivana Maida, et al.
HIV Clinical Trials|June 15, 2010
A microsimulation of the cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individualsFelicitas C Kühne, Jeremy Chancellor, Patrick Mollon, et al.
HIV Clinical Trials|June 15, 2010
Twelve-year experience of nevirapine use: benefits and convenience for long-term management in a French cohort of HIV-1-infected patientsVéronique Reliquet, C Allavena, P Morineau-Le Houssine, et al.
HIV Clinical Trials|August 26, 2010
Efficacy and safety of maraviroc versus efavirenz, both with zidovudine/lamivudine: 96-week results from the MERIT studyJuan Sierra-Madero, Giovanni Di Perri, Robin Wood, et al.
HIV Clinical Trials|August 26, 2010
Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United StatesAnita J Brogan, Joseph Mrus, Andrew Hill, et al.
HIV Clinical Trials|January 18, 2011
Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancyMarco Floridia, Marina Ravizza, Carmela Pinnetti, et al.
HIV Clinical Trials|January 18, 2011
Monthly unannounced pill counts for monitoring HIV treatment adherence: tests for self-monitoring and reactivity effectsSeth C Kalichman, Christina Amaral, Connie Swetsze, et al.
Pageof 68